Cargando…
Corrigendum to “Traditional Chinese medicine for COVID-19 treatment” [Pharmacol. Res. 155 (2020) 104743]
Autores principales: | Ren, Jun-ling, Zhang, Ai-Hua, Wang, Xi-Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270570/ https://www.ncbi.nlm.nih.gov/pubmed/32222346 http://dx.doi.org/10.1016/j.phrs.2020.104768 |
Ejemplares similares
-
Corrigendum to “The new entries in the therapeutic armamentarium: The small molecule JAK inhibitors” [Pharmacol. Res. 147 (2019) 104392]
por: Bechman, Katie, et al.
Publicado: (2020) -
Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761]
por: Runfeng, Li, et al.
Publicado: (2021) -
Traditional Chinese medicine for COVID-19 treatment
por: Ren, Jun-ling, et al.
Publicado: (2020) -
Corrigendum to “Naringerin as candidate drug against SARS-CoV-2: The role for TPC2 genomic variants in COVID-19” [Pharmacol. Res. 164 (2021) 105402]
por: Di Maria, Emilio, et al.
Publicado: (2021) -
Corrigendum to “Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost” [Biochem. Pharmacol. 178 (2020) 114057]
por: Mohammed El Tabaa, Manar, et al.
Publicado: (2020)